MENU
CYPH
AS OF
Jan 30 closing price
Price
$0.75
Change
+$0.05 (+7.14%)
Capitalization
42.32M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CYPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cypherpunk Technologies (CYPH) Ownership - Who owns Cypherpunk Technologies?

Cypherpunk Technologies Inc is a company developing novel therapies for patients with cancer and implementing a digital asset treasury plan focused on Zcash... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Financial
Capitalization
42.32M
P/E Ratio
N/A
Total Cash
9.69M
Projected Growth
N/A
Total Debt
38K
Revenue
N/A
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash/Share
0.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CYPH
Capitalization
42.3M
P/E Ratio
N/A
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash
9.69M
Total Cash/Share
0.17
Total Debt
38K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.7M
P/B Ratio
15.67
Cash Flow
N/A
Earnings
-1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
41K
Current Ratio
1.21
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-53.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-132.94
Shares Held By Institutions
6.29M
Shares Outstanding - Current
56.7M
Total Liabilities
8.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-35.741
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CYPH
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for CYPH
A.I. Advisor
published General Information

General Information

a company, which engages in clinical stage immuno-oncology

Industry InvestmentManagers

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A